The role of pathology in the management of patients with endometrial carcinoma-Reference-Cited by-同舟云学术

The role of pathology in the management of patients with endometrial carcinoma

Published:2017-05 Issue:11 Volume:13 Page:1003-1020
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Bartosch Carla¹²³⁴,Pires Mónica⁴⁵,Jerónimo Carmen³⁴⁶,Lopes José Manuel²⁷⁸

Affiliation:

1. Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal

2. Department of Pathology and Oncology, Medical Faculty, University of Porto, Porto, Portugal

3. Cancer Biology & Epigenetics Group, Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal

4. Porto Comprehensive Cancer Center (PCCC), Porto, Portugal

5. Department of Gynecology, Portuguese Oncology Institute of Porto, Porto, Portugal

6. Department of Pathology & Molecular Immunology, Institute of Biomedical Sciences Abel Salazar-ICBAS, University of Porto, Porto, Portugal

7. Department of Pathology, Centro Hospitalar de São João, Porto, Portugal

8. IPATIMUP (Institute of Molecular Pathology & Immunology, University of Porto) & I3S – Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal

Abstract

Pathology plays a critical role in every step in the management of endometrial carcinoma patients. In this review, we describe the state of the art of pathological examination, including examination of endometrium biopsy; intra-operative evaluation with gross examination and frozen section; and grossing of hysterectomy specimen and its histological and immunohistochemistry study. The main pathologic findings in each step are described, as well as limitations and difficulties that may ensue. We highlight the important pathologic parameters that determine treatment options and prognosis of endometrial cancer patients.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fon-2016-0570

Reference100 articles.

1. Howlader N, Noone AM, Krapcho M SEER Cancer Statistics Review, 1975–2008, National Cancer Institute. http://seer.cancer.gov/csr/1975_2008

2. Geographic and temporal variations in cancer of the corpus uteri: Incidence and mortality in pre- and postmenopausal women in Europe

3. Steliarova-Foucher E, O’Callaghan M, Ferlay J European cancer observatory: cancer incidence, mortality, prevalence and survival in Europe. Version 1.0 (September 2012) European Network of Cancer Registries, International Agency for Research on Cancer (2013). http://eco.iarc.fr

4. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

5. Two pathogenetic types of endometrial carcinoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pain nursing for gynecologic cancer patients;Frontiers in Oncology;2023-07-26

2. Research Progress of Hydrogel in the Application of Gynecologic Malignant Tumor Treatment;Advances in Clinical Medicine;2023

3. LINC01857 Exacerbates the Malignant Behaviors of Endometrial Carcinoma Cells by Sponging miR-19b-3p and Recruiting ELAVL1 to Upregulate MYCN;Gynecologic and Obstetric Investigation;2022-12-27

4. Lidocaine inhibits the proliferation and migration of endometrial cancer cells, and promotes apoptosis by inducing autophagy;Oncology Letters;2022-08-17

5. Interdisciplinary Approach in Solid Tumors and Cutaneous Cancers;Interdisciplinary Cancer Research;2022